176 Enzymatic conversion of blood group O human kidneys to rare Bombay type during hypothermic machine perfusion

Abstract Background ABO blood grouping compatibility restrictions present one of the first hurdles to recipient-donor matching in transplantation. While blood group O individuals would usually be described as ‘universal’ donors, a rare blood group called Bombay type is incompatible even with blood group O. Here, we describe the first use of a bacterial fucosidase enzyme called FucOB to convert human blood group O kidneys to the rare Bombay type during ex vivo hypothermic machine perfusion (HMP). Methods Four blood group O human kidneys declined for transplantation and offered for research were recruited to this study. The kidneys underwent 24h HMP with 5ug/ml FucOB and H antigen loss was assessed in serial biopsies throughout perfusion using immunofluorescence microscopy. Functional perfusion parameters were assessed continuously during perfusion, namely renal blood flow (RBF), mean arterial pressure (MAP) and intrarenal resistance (IRR). Results Haemodynamic parameters during 24h HMP were stable, with mean RBF of 70±6 ml/min/100g (mean ± SD), MAP of 22±1mmHg, and IRR of 0.19±0.02 mmHg/ml/min/100g. The mean temperature during perfusion was 3.5±0.3oC. Regarding blood group antigen expression, strong H antigen staining was observed in pre-perfusion samples. After 6h HMP + FucOB, H antigen expression was absent from the renal vasculature, demonstrating conversion to Bombay type. Conclusions This work successfully showed H antigen removal from human kidneys during HMP. This demonstrates the expansion of enzymatic blood group antigen conversion to provide transplant solutions to rare blood types.

Authors

Institutions

Publication Details

Journal
British journal of surgery
Published
2025-03-01
DOI
https://doi.org/10.1093/bjs/znaf042.016
Primary Topic
Xenotransplantation and immune response
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

176 Enzymatic conversion of blood group O human kidneys to rare Bombay type during hypothermic machine perfusion

Michael L. Nicholson, Serena MacMillan, Marcelo E. Guerin, Fumiichiro Yamamoto et al.
British journal of surgery
Xenotransplantation and immune response
article

176 Enzymatic conversion of blood group O human kidneys to rare Bombay type during hypothermic machine perfusion

Michael L. Nicholson, Serena MacMillan, Marcelo E. Guerin, Fumiichiro Yamamoto, Emili Cid, Itxaso Anso, Sarah A. Hosgood, Léonie Walker-Panse
article en

Abstract

Abstract Background ABO blood grouping compatibility restrictions present one of the first hurdles to recipient-donor matching in transplantation. While blood group O individuals would usually be described as ‘universal’ donors, a rare blood group called Bombay type is incompatible even with blood group O. Here, we describe the first use of a bacterial fucosidase enzyme called FucOB to convert human blood group O kidneys to the rare Bombay type during ex vivo hypothermic machine perfusion (HMP). Methods Four blood group O human kidneys declined for transplantation and offered for research were recruited to this study. The kidneys underwent 24h HMP with 5ug/ml FucOB and H antigen loss was assessed in serial biopsies throughout perfusion using immunofluorescence microscopy. Functional perfusion parameters were assessed continuously during perfusion, namely renal blood flow (RBF), mean arterial pressure (MAP) and intrarenal resistance (IRR). Results Haemodynamic parameters during 24h HMP were stable, with mean RBF of 70±6 ml/min/100g (mean ± SD), MAP of 22±1mmHg, and IRR of 0.19±0.02 mmHg/ml/min/100g. The mean temperature during perfusion was 3.5±0.3oC. Regarding blood group antigen expression, strong H antigen staining was observed in pre-perfusion samples. After 6h HMP + FucOB, H antigen expression was absent from the renal vasculature, demonstrating conversion to Bombay type. Conclusions This work successfully showed H antigen removal from human kidneys during HMP. This demonstrates the expansion of enzymatic blood group antigen conversion to provide transplant solutions to rare blood types.

British journal of surgeryVol. 112(Supplement_6)
Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), University of Cambridge (GB), Josep Carreras Leukaemia Research Institute (ES), Institut Européen de Chimie et Biologie (FR), Institut Polytechnique de Bordeaux (FR), Institut de Biologia Molecular de Barcelona (ES)
Good health and well-being
Openalex Percentile: Top 92%
Xenotransplantation and immune response
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.